-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide: This article will be from this round of collection of the lowest unit price analysis, take you into the era of drug prices 1 cent.
24, 2020, with the joint procurement office in Shanghai Sunshine Pharmaceutical Procurement Network published "on the announcement of the results of the national centralized procurement of drugs in the notice", the third batch of national drug collection came to an end.
this article will be from this round of collection of the lowest unit price analysis, take you into the era of drug prices 1 cent.
1, the third round of national drug collection winning the lowest price out of the current round of the 67 standards, the lowest price of the drug is Chongqing Core Pharmaceutical (Group) Co., Ltd. produced Katopli tablets (25mg), the price of a single tablet is only 0.0142 yuan, lower than the highest effective declared price of 95.83 percent.
, there are 10 product regulations in the list of the lowest bid price of less than 1 dime. Table
1 Compared with the highest effective declared price, the maximum price of the third round of drugs, the reduction of more than 25% of the product regulations was 90% or more, and the largest decrease (the reduction (the lowest price - the highest effective declared price) / the highest effective declared price) was the largest production of hydrochloric acid tablets (10mg), a decrease of 98.72%.
Figure 1 The third round of price reduction of more than 90% of the product regulation II, the lowest price of the national drug collection top list through the 4 batches (4 plus 7 pilot, expansion, second batch, third batch) of the lowest price of each product, of which, there are 19 drugs, 21 varieties of single-piece / grain price is less than 1 dime.
As can be known from the table below, the third batch of drugs covered the top three lowest prices, namely, captopril tablets (25mg), metformin hydrochloride tablets (0.25g), chlorine flat tablets (25mg), the price of a single tablet into the 1 cent era.
the second batch of drugs in the second batch of drugs ranked immediately after, the 4 plus 7 expansion into the 2 drugs, while the lowest price of the 4 plus 7 pilot drugs did not enter the ranking.
, it can be seen that the competition for low-cost drugs is being more and more intense. table
Table 2 The lowest price of Chinese pharmaceutical collection top three, the market decline in the collection price significantly on the national drug collection price of the lowest top three drugs analysis, and the market price comparison shows that Chongqing Core Pharmaceuticals (Group) Co., Ltd. produced Katopli tablets (25mg) in 2019 the lowest bid price of 0.29 yuan / tablet, 2020 provincial and municipal list price of 0.08 yuan / tablet.
the winning bid price of this round is lower than the lowest winning bid price of 95.11% and 82.29% in 2019 and 2020, respectively.
Figure 2 Catoprile tablets (25mg) market bid minimum preparation price comparison note: market list price (highest price, median, average price, lowest price) data from pharmaceutical data - drug winning database Chongqing Core Pharmaceuticals (Group) Co., Ltd. Production of metformin hydrochloride tablets (0.25g) in 2019 provinces and cities won the lowest bid price of 0.22 yuan / piece, in 2020 the lowest bid price of 0.11 yuan / piece.
the winning bid price of this round is lower than the lowest winning bid price of 93.02% and 86.04% in 2019 and 2020, respectively.
Figure 3 The minimum price of the smallest preparation in the market for metformin hydrochloride tablets (0.25g) is compared with the lowest price of 0.08 yuan per tablet in 2019 for the provinces and cities produced by Jiangsu Enhua Pharmaceutical Co., Ltd., and 0.09 yuan per tablet for the provinces and cities in 2020.
the winning bid price of this round is lower than the lowest winning bid price of 80.25 percent and 82.44 percent in 2019 and 2020, respectively.
price comparison of the smallest preparation in the market for 4 chlorine-nitrogen flat tablets (25 mg).